BFH 772, also known as BFH-772, is primarily utilized in the field of pharmaceutical research and development. It is investigated for its potential therapeutic effects, particularly in the treatment of inflammatory diseases. Researchers are exploring its efficacy in modulating specific biological pathways that are implicated in chronic inflammation, making it a candidate for conditions such as rheumatoid arthritis and other autoimmune disorders. Additionally, BFH-772 is being studied for its role in oncology, where it may help in inhibiting tumor growth or enhancing the effectiveness of existing cancer therapies. Its application in preclinical studies aims to determine its safety, pharmacokinetics, and pharmacodynamics, which are crucial for advancing it to clinical trials.